Primary Category:
Treatment Protocols
Disease Category:
Genitourinary, Prostate Metastatic
Status:
Temporarily Closed
CASPAR – A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
Eligible for screening study DCP 001
A031902 is temporarily suspended to new patient registration (OPEN Step 0), effective April 10, 2023.
A031902 is temporarily suspended to new patient registration (OPEN Step 2), effective May 10, 2023.
NCT#04455750
